Arcus Biosciences Inc (RCUS)
15.56
-0.39
(-2.45%)
USD |
NYSE |
May 07, 16:00
15.56
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Free Cash Flow: -330.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -330.00M |
| September 30, 2023 | -306.00M |
| June 30, 2023 | -316.00M |
| March 31, 2023 | -326.00M |
| December 31, 2022 | 426.00M |
| September 30, 2022 | 425.64M |
| June 30, 2022 | 447.02M |
| March 31, 2022 | 438.96M |
| December 31, 2021 | -282.00M |
| September 30, 2021 | -263.15M |
| June 30, 2021 | 13.66M |
| March 31, 2021 | 69.53M |
| December 31, 2020 | 108.00M |
| Date | Value |
|---|---|
| September 30, 2020 | 149.85M |
| June 30, 2020 | -93.30M |
| March 31, 2020 | -89.41M |
| December 31, 2019 | -75.39M |
| September 30, 2019 | -73.08M |
| June 30, 2019 | -58.03M |
| March 31, 2019 | -49.90M |
| December 31, 2018 | -46.74M |
| September 30, 2018 | -24.08M |
| June 30, 2018 | -36.26M |
| March 31, 2018 | -33.14M |
| December 31, 2017 | -30.57M |
Free Cash Flow Range, Past 5 Years
-330.00M
Minimum
Dec 2023
447.02M
Maximum
Jun 2022
-7.037M
Average
-73.08M
Median
Sep 2019
Free Cash Flow Benchmarks
| Gilead Sciences Inc | 8.481B |
| Catalyst Pharmaceuticals Inc | 61.86M |
| Integra Lifesciences Holdings Corp | 73.09M |
| Vertex Pharmaceuticals Inc | 3.279B |
| Adverum Biotechnologies Inc | -91.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -88.00M |
| Cash from Investing (Quarterly) | 28.00M |
| Cash from Financing (Quarterly) | 3.00M |
| Free Cash Flow Per Share (Quarterly) | -1.25 |
| Free Cash Flow to Equity (Quarterly) | -94.00M |
| Free Cash Flow to Firm (Quarterly) | -94.00M |
| Free Cash Flow Yield | -28.66% |